Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma

被引:33
作者
Faried, A [1 ]
Nakajima, M [1 ]
Sohda, M [1 ]
Miyazaki, T [1 ]
Kato, H [1 ]
Kuwano, H [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci Surg 1, Maebashi, Gumma 3718511, Japan
来源
EJSO | 2005年 / 31卷 / 04期
关键词
RhoA; esophageal cancer; immunohistochemistry; prognosis;
D O I
10.1016/j.ejso.2004.12.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims. The aim of this study was to clarify the clinico-pathologic outcome and prognostic significance of RhoA in esophageal squamous cell carcinoma (ESCC). Methods. Immunohistochemical staining for RhoA was performed on surgical specimens obtained from 122 patients with ESCC. Results. There were significant correlations among RhoA overexpression and TNM clinical, classification (depth of invasion, P=0.028; presence of regional, lymph node metastasis, P=0.009; presence of distant metastasis, P=0.003; staging P=0.006), lymphatic invasion (P=0.002), and blood-vessel invasion (P=0.004). The five-year survival rates for ESCC patients with RhoA overexpression were significantly lower than those in patients with RhoA under- expression (P=0.002). Conclusions. Our results demonstrated immunohistochemically that the expression of RhoA protein appeared to be correlated with tumour progression of ESCC. Patients with RhoA overexpression tended to have poor prognosis compared with patients with RhoA under- expression. (c) 2004 Etsevier Ltd. All rights reserved.
引用
收藏
页码:410 / 414
页数:5
相关论文
共 26 条
[1]   Motility-related proteins as markers for head and neck squamous cell cancer [J].
Abraham, MT ;
Kuriakose, MA ;
Sacks, PG ;
Yee, H ;
Chiriboga, L ;
Bearer, EL ;
Delacure, MD .
LARYNGOSCOPE, 2001, 111 (07) :1285-1289
[2]   PAK to the future [J].
Bagrodia, S ;
Cerione, RA .
TRENDS IN CELL BIOLOGY, 1999, 9 (09) :350-355
[3]  
BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
[4]   CODING SEQUENCE OF HUMAN RHO CDNAS CLONE-6 AND CLONE-9 [J].
CHARDIN, P ;
MADAULE, P ;
TAVITIAN, A .
NUCLEIC ACIDS RESEARCH, 1988, 16 (06) :2717-2717
[5]  
del Peso L, 1997, ONCOGENE, V15, P3047
[6]  
Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO
[7]  
2-B
[8]   Rho GTPases and the actin cytoskeleton [J].
Hall, A .
SCIENCE, 1998, 279 (5350) :509-514
[9]   Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma [J].
Horiuchi, A ;
Imai, T ;
Wang, CJ ;
Ohira, S ;
Feng, YZ ;
Nikaido, T ;
Konishi, I .
LABORATORY INVESTIGATION, 2003, 83 (06) :861-870
[10]   An essential part for Rho-associated kinase in the transcellular invasion of tumor cells [J].
Itoh, K ;
Yoshioka, K ;
Akedo, H ;
Uehata, M ;
Ishizaki, T ;
Narumiya, S .
NATURE MEDICINE, 1999, 5 (02) :221-225